{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:01:04Z","timestamp":1775804464595,"version":"3.50.1"},"reference-count":157,"publisher":"Elsevier","isbn-type":[{"value":"9780128211182","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.irn.2020.04.003","type":"book-chapter","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T09:07:35Z","timestamp":1591693655000},"page":"71-101","source":"Crossref","is-referenced-by-count":7,"title":["Maximizing placebo response in neurological clinical practice"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.irn.2020.04.003_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JHD-2012-120002","article-title":"The patient education program for Huntington's disease (PEP-HD)","volume":"1","author":"A'Campo","year":"2012","journal-title":"Journal of Huntington's Disease"},{"key":"10.1016\/bs.irn.2020.04.003_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.parkreldis.2009.07.009","article-title":"The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers","volume":"16","author":"A'Campo","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0020","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.sleep.2013.08.001","article-title":"Minimal clinically significant change for the international restless legs syndrome study group rating scale in clinical trials is a score of 3","volume":"14","author":"Allen","year":"2013","journal-title":"Sleep Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0025","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1523\/JNEUROSCI.19-01-00484.1999","article-title":"Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems","volume":"19","author":"Amanzio","year":"1999","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.04.003_bb0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1017\/S1041610211002420","article-title":"A systematic review of adverse events in the placebo arm of donepezil trials: The role of cognitive impairment","volume":"24","author":"Amanzio","year":"2012","journal-title":"International Psychogeriatrics"},{"key":"10.1016\/bs.irn.2020.04.003_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pain.2009.07.010","article-title":"A systematic review of adverse events in placebo groups of anti-migraine clinical trials","volume":"146","author":"Amanzio","year":"2009","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.psyneuen.2010.06.006","article-title":"Baseline \u201cstate anxiety\u201d influences HPA-axis sensitivity to one sham-controlled HF-rTMS session applied to the right dorsolateral prefrontal cortex","volume":"36","author":"Baeken","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0045","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.pain.2013.05.012","article-title":"Responding to nocebos through observation: Social contagion of negative emotions","volume":"154","author":"Benedetti","year":"2013","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.neuron.2014.10.023","article-title":"Placebo effects: From the neurobiological paradigm to translational implications","volume":"84","author":"Benedetti","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2020.04.003_bb0055","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm.2435","article-title":"Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors","volume":"17","author":"Benedetti","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pain.2005.12.016","article-title":"Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective","volume":"121","author":"Benedetti","year":"2006","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0065","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S1474-4422(16)00066-1","article-title":"Increasing uncertainty in CNS clinical trials: The role of placebo, nocebo, and Hawthorne effects","volume":"15","author":"Benedetti","year":"2016","journal-title":"The Lancet. Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/clpt.2011.206","article-title":"Hidden administration of drugs","volume":"90","author":"Benedetti","year":"2011","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/bs.irn.2020.04.003_bb0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nn1250","article-title":"Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus","volume":"7","author":"Benedetti","year":"2004","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.irn.2020.04.003_bb0080","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1113\/jphysiol.2009.169425","article-title":"Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response","volume":"587","author":"Benedetti","year":"2009","journal-title":"Journal of Physiology (London)"},{"key":"10.1016\/bs.irn.2020.04.003_bb0085","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/j.pain.0000000000000870","article-title":"Side effects can enhance treatment response through expectancy effects: An experimental analgesic randomized controlled trial","volume":"158","author":"Berna","year":"2017","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0090","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2014.8342","article-title":"Avoiding nocebo effects to optimize treatment outcome","volume":"312","author":"Bingel","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/bs.irn.2020.04.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001244","article-title":"The effect of treatment expectation on drug efficacy: Imaging the analgesic benefit of the opioid remifentanil","volume":"3","author":"Bingel","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170988","article-title":"Trust in the health care professional and health outcome: A meta-analysis","volume":"12","author":"Birkh\u00e4uer","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2020.04.003_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101822","article-title":"When and why placebo-prescribing is acceptable and unacceptable: A focus group study of patients' views","volume":"9","author":"Bishop","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2020.04.003_bb0110","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.9955","article-title":"Informing adults with Back pain about placebo effects: Randomized controlled evaluation of a new website with potential to improve informed consent in clinical research","volume":"21","author":"Bishop","year":"2019","journal-title":"Journal of Medical Internet Research"},{"key":"10.1016\/bs.irn.2020.04.003_bb0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00213-011-2233-4","article-title":"Interaction between expectancies and drug effects: An experimental investigation of placebo analgesia with caffeine as an active placebo","volume":"215","author":"Bj\u00f8rkedal","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0120","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1056\/NEJMp0805631","article-title":"The future of primary care: Transforming practice","volume":"359","author":"Bodenheimer","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1177\/2054270416681434","article-title":"Does the model of additive effect in placebo research still hold true? A narrative review","volume":"8","author":"Boehm","year":"2017","journal-title":"JRSM Open"},{"key":"10.1016\/bs.irn.2020.04.003_bb0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/mdc3.12651","article-title":"Neurostimulation for functional neurological disorder: Evaluating longitudinal neurophysiology","volume":"5","author":"Burke","year":"2018","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.1016\/bs.irn.2020.04.003_bb0135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.parkreldis.2019.06.015","article-title":"Verbal communication about drug dosage balances drug reduction in Parkinson's disease: Behavioral and electrophysiological evidences","volume":"65","author":"Carlino","year":"2019","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.clinthera.2017.01.031","article-title":"The placebo and Nocebo phenomena: Their clinical management and impact on treatment outcomes","volume":"39","author":"Chavarria","year":"2017","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/bs.irn.2020.04.003_bb0145","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1177\/0269881112458730","article-title":"Warning about side effects can increase their occurrence: An experimental model using placebo treatment for sleep difficulty","volume":"26","author":"Colagiuri","year":"2012","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2020.04.003_bb0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuroscience.2015.08.017","article-title":"The placebo effect: From concepts to genes","volume":"307","author":"Colagiuri","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2020.04.003_bb0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1474-4422(04)00908-1","article-title":"Overt versus covert treatment for pain, anxiety, and Parkinson's disease","volume":"3","author":"Colloca","year":"2004","journal-title":"Lancet Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0160","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1037\/0022-3514.36.8.805","article-title":"Social modeling influences on sensory decision theory and psychophysiological indexes of pain","volume":"36","author":"Craig","year":"1978","journal-title":"Journal of Personality and Social Psychology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0165","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/mds.24062","article-title":"Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease","volume":"27","author":"Cubo","year":"2012","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0170","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/mds.25365","article-title":"Impact of placebo assignment in clinical trials of tic disorders: Placebo in Tic disorders","volume":"28","author":"Cubo","year":"2013","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0175","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1468-1331.2012.03719.x","article-title":"The powerful pre-treatment effect: Placebo responses in restless legs syndrome trials","volume":"19","author":"de la Fuente-Fern\u00e1ndez","year":"2012","journal-title":"European Journal of Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0180","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1126\/science.1060937","article-title":"Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's disease","volume":"293","author":"de la Fuente-Fern\u00e1ndez","year":"2001","journal-title":"Science"},{"key":"10.1016\/bs.irn.2020.04.003_bb0185","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1468-2982.1999.019008699.x","article-title":"Unbalanced randomization influences placebo response: Scientific versus ethical issues around the use of placebo in migraine trials","volume":"19","author":"Diener","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/bs.irn.2020.04.003_bb0190","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tips.2011.12.001","article-title":"Utilizing placebo mechanisms for dose reduction in pharmacotherapy","volume":"33","author":"Doering","year":"2012","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/bs.irn.2020.04.003_bb0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3923","article-title":"The placebo response in medicine: Minimize, maximize or personalize?","volume":"12","author":"Enck","year":"2013","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.irn.2020.04.003_bb0200","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/WNL.0000000000001282","article-title":"Placebo effect of medication cost in Parkinson disease: A randomized double-blind study","volume":"84","author":"Espay","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000490354","article-title":"Implications of placebo and Nocebo effects for clinical practice: Expert consensus","volume":"87","author":"Evers","year":"2018","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1016\/bs.irn.2020.04.003_bb0210","first-page":"126","article-title":"Clinical strategies for maximizing the placebo effect","volume":"43","author":"F\u00e4ssler","year":"2011","journal-title":"Family Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1741-7015-8-15","article-title":"Frequency and circumstances of placebo use in clinical practice\u2014A systematic review of empirical studies","volume":"8","author":"F\u00e4ssler","year":"2010","journal-title":"BMC Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0220","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/mds.113","article-title":"Placebo and nocebo responses in other movement disorders besides Parkinson's disease: How much do we know?","volume":"33","author":"Ferreira","year":"2018","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0225","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(09)61706-2","article-title":"Biological, clinical, and ethical advances of placebo effects","volume":"375","author":"Finniss","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/bs.irn.2020.04.003_bb0230","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1098\/rstb.2010.0407","article-title":"The relation of emotions to placebo responses","volume":"366","author":"Flaten","year":"2011","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"key":"10.1016\/bs.irn.2020.04.003_bb0235","first-page":"257","article-title":"Predictors of placebo response in peripheral neuropathic pain: Insights from pregabalin clinical trials","volume":"8","author":"Freeman","year":"2015","journal-title":"Journal of Pain Research"},{"key":"10.1016\/bs.irn.2020.04.003_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cortex.2013.12.003","article-title":"Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients","volume":"60","author":"Frisaldi","year":"2014","journal-title":"Cortex"},{"key":"10.1016\/bs.irn.2020.04.003_bb0245","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/mds.27142","article-title":"The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning","volume":"32","author":"Frisaldi","year":"2017","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0250","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/brain\/awm244","article-title":"Where dopamine meets opioids: A meta-analysis of the placebo effect in restless legs syndrome treatment studies","volume":"131","author":"Fulda","year":"2008","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0255","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neurol.2019.08.007","article-title":"Functional movement disorders","volume":"176","author":"Galli","year":"2019","journal-title":"Revue Neurologique"},{"key":"10.1016\/bs.irn.2020.04.003_bb0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neurol.2017.11.003","article-title":"Motor functional neurological disorders: An update","volume":"174","author":"Garcin","year":"2018","journal-title":"Revue Neurologique (Paris)"},{"key":"10.1016\/bs.irn.2020.04.003_bb0265","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fneur.2017.00338","article-title":"Impact of Transcranial magnetic stimulation on functional movement disorders: Cortical modulation or a behavioral effect?","volume":"8","author":"Garcin","year":"2017","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0270","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/jnnp-2012-304062","article-title":"Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders","volume":"84","author":"Garcin","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2020.04.003_bb0275","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/abm\/kaz005","article-title":"A positive mood induction for reducing the formation of nocebo effects from side effect information","volume":"53","author":"Geers","year":"2019","journal-title":"Annals of Behavioral Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0280","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jpsychores.2004.08.011","article-title":"Reconsidering the role of personality in placebo effects: Dispositional optimism, situational expectations, and the placebo response","volume":"58","author":"Geers","year":"2005","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1016\/bs.irn.2020.04.003_bb0285","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1037\/a0034005","article-title":"Why does choice enhance treatment effectiveness? Using placebo treatments to demonstrate the role of personal control","volume":"105","author":"Geers","year":"2013","journal-title":"Journal of Personality and Social Psychology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0290","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jpain.2010.02.014","article-title":"Dispositional optimism predicts placebo analgesia","volume":"11","author":"Geers","year":"2010","journal-title":"The Journal of Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0295","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jpsychores.2018.11.006","article-title":"Quality of life in functional movement disorders is as altered as in organic movement disorders","volume":"116","author":"Gendre","year":"2019","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1016\/bs.irn.2020.04.003_bb0300","doi-asserted-by":"crossref","first-page":"101389","DOI":"10.1016\/j.msard.2019.101389","article-title":"Nocebo in multiple sclerosis trials: A meta-analysis on oral and newer injectable disease-modifying treatments","volume":"36","author":"Gklinos","year":"2019","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0305","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/WNL.0b013e3181b1640b","article-title":"Jean-Martin Charcot and his vibratory chair for Parkinson disease","volume":"73","author":"Goetz","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0310","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/mds.10504","article-title":"Impact of placebo assignment in clinical trials of Parkinson's disease","volume":"18","author":"Goetz","year":"2003","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0315","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/mds.21897","article-title":"Placebo influences on dyskinesia in Parkinson's disease","volume":"23","author":"Goetz","year":"2008","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0320","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/mds.21894","article-title":"Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions","volume":"23","author":"Goetz","year":"2008","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0325","doi-asserted-by":"crossref","first-page":"106491","DOI":"10.1016\/j.yebeh.2019.106491","article-title":"Use of noninvasive induction techniques in the diagnosis of PNES","volume":"99","author":"Gogia","year":"2019","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/bs.irn.2020.04.003_bb0330","doi-asserted-by":"crossref","first-page":"106467","DOI":"10.1016\/j.yebeh.2019.106467","article-title":"Patients' knowledge on epilepsy and SUDEP improves after a semi-structured health interview","volume":"99","author":"Guti\u00e9rrez-Viedma","year":"2019","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/bs.irn.2020.04.003_bb0335","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molmed.2015.02.009","article-title":"Genetics and the placebo effect: The placebome","volume":"21","author":"Hall","year":"2015","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0340","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fpsyt.2019.00653","article-title":"Placebo economics: A systematic review about the economic potential of utilizing the placebo effect","volume":"10","author":"Hamberger","year":"2019","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.irn.2020.04.003_bb0345","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fphar.2019.00077","article-title":"Nocebo effects and negative suggestions in daily clinical practice\u2013forms, impact and approaches to avoid them","volume":"10","author":"Hansen","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0350","first-page":"459","article-title":"Nocebo phenomena in medicine: Their relevance in everyday clinical practice","volume":"109","author":"H\u00e4user","year":"2012","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"10.1016\/bs.irn.2020.04.003_bb0355","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1051\/medsci\/2019127","article-title":"Le placebo \u00e0 l'h\u00f4pital: Regard sur son utilisation dans les services de m\u00e9decine polyvalente","volume":"35","author":"H\u00e9ron","year":"2019","journal-title":"Medical Science (Paris)"},{"key":"10.1016\/bs.irn.2020.04.003_bb0360","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3389\/fpsyt.2018.00706","article-title":"Effects of placebo interventions on subjective and objective markers of appetite\u2013a randomized controlled trial","volume":"9","author":"Hoffmann","year":"2018","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.irn.2020.04.003_bb0365","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3389\/fpsyg.2014.01079","article-title":"Prediction of placebo responses: A systematic review of the literature","volume":"5","author":"Horing","year":"2014","journal-title":"Frontiers in Psychology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0370","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/2013.jamaneurol.382","article-title":"A randomized, double-blind, placebo-controlled study of Latrepirdine in patients with mild to moderate Huntington disease","volume":"70","author":"HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network","year":"2013","journal-title":"JAMA Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0375","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1037\/hea0000499","article-title":"Harnessing the placebo effect: Exploring the influence of physician characteristics on placebo response","volume":"36","author":"Howe","year":"2017","journal-title":"Health Psychology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058247","article-title":"Placebo use in the United Kingdom: Results from a National Survey of primary care practitioners","volume":"8","author":"Howick","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2020.04.003_bb0385","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1186\/s13063-018-3042-4","article-title":"Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials","volume":"19","author":"Howick","year":"2018","journal-title":"Trials"},{"issue":"1","key":"10.1016\/bs.irn.2020.04.003_bb0390","article-title":"Placebo interventions for all clinical conditions","author":"Hr\u00f3bjartsson","year":"2010","journal-title":"Cochrane Database System Review"},{"key":"10.1016\/bs.irn.2020.04.003_bb0395","doi-asserted-by":"crossref","first-page":"f3757","DOI":"10.1136\/bmj.f3757","article-title":"Patients' attitudes about the use of placebo treatments: Telephone survey","volume":"347","author":"Hull","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/bs.irn.2020.04.003_bb0400","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial","volume":"66","author":"Huntington Study Group","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0405","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cct.2013.08.012","article-title":"Detecting a clinically meaningful change in tic severity in Tourette syndrome: A comparison of three methods","volume":"36","author":"Jeon","year":"2013","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/bs.irn.2020.04.003_bb0410","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009655","article-title":"To what extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials","volume":"5","author":"Jonas","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/bs.irn.2020.04.003_bb0415","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006175","article-title":"Altered placebo and drug labeling changes the outcome of episodic migraine attacks","volume":"6","author":"Kam-Hansen","year":"2014","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015591","article-title":"Placebos without deception: A randomized controlled trial in irritable bowel syndrome","volume":"5","author":"Kaptchuk","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2020.04.003_bb0425","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJMp1504023","article-title":"Placebo effects in medicine","volume":"373","author":"Kaptchuk","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0430","doi-asserted-by":"crossref","first-page":"k3889","DOI":"10.1136\/bmj.k3889","article-title":"Open label placebo: Can honestly prescribed placebos evoke meaningful therapeutic benefits?","volume":"363","author":"Kaptchuk","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/bs.irn.2020.04.003_bb0435","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JPD-2012-12079","article-title":"Vibration therapy for Parkinson's disease: Charcot's studies revisited","volume":"2","author":"Kapur","year":"2012","journal-title":"Journal of Parkinson's Disease"},{"key":"10.1016\/bs.irn.2020.04.003_bb0440","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jns.2007.06.008","article-title":"Distinguishing psychogenic and essential tremor","volume":"263","author":"Kenney","year":"2007","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/bs.irn.2020.04.003_bb0445","first-page":"636","article-title":"Family physicians believe the placebo effect is therapeutic but often use real drugs as placebos","volume":"42","author":"Kermen","year":"2010","journal-title":"Family Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109014","article-title":"The effect of treatment history on therapeutic outcome: Psychological and neurobiological underpinnings","volume":"9","author":"Kessner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2020.04.003_bb0455","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fpsyt.2019.00407","article-title":"Placebo effect in the treatment of depression and anxiety","volume":"10","author":"Kirsch","year":"2019","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.irn.2020.04.003_bb0460","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1746-1561.1973.tb03741.x","article-title":"Relationships between expectations of teachers and performance of students (Pygmalion in the classroom)","volume":"43","author":"Kohn","year":"1973","journal-title":"The Journal of School Health"},{"key":"10.1016\/bs.irn.2020.04.003_bb0465","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.pain.2009.09.033","article-title":"Prefrontal cortex modulates placebo analgesia","volume":"148","author":"Krummenacher","year":"2010","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2019.04.015","article-title":"Nocebo response in Parkinson's disease: A systematic review and meta-analysis","author":"Leal Rato","year":"2019","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0475","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1532-5415.1990.tb01472.x","article-title":"Pygmalion in the nursing home. The effects of caregiver expectations on patient outcomes","volume":"38","author":"Learman","year":"1990","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/bs.irn.2020.04.003_bb0480","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archgenpsychiatry.2010.88","article-title":"Effects of expectation on placebo-induced dopamine release in Parkinson disease","volume":"67","author":"Lidstone","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/bs.irn.2020.04.003_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202211","article-title":"How often do general practitioners use placebos and non-specific interventions? Systematic review and meta-analysis of surveys","volume":"13","author":"Linde","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2020.04.003_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092938","article-title":"The use of placebo and non-specific therapies and their relation to basic professional attitudes and the use of complementary therapies among German physicians\u2014A cross-sectional survey","volume":"9","author":"Linde","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2020.04.003_bb0495","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/mds.25471","article-title":"Effect of expectancy and personality on cortical excitability in Parkinson's disease","volume":"28","author":"Lou","year":"2013","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0500","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.pain.2011.07.010","article-title":"Variability in placebo analgesia and the role of fear of pain\u2014An ERP study","volume":"152","author":"Lyby","year":"2011","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0505","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejpain.2007.03.002","article-title":"Placebo response in the prophylaxis of migraine: A meta-analysis","volume":"12","author":"Macedo","year":"2008","journal-title":"European Journal of Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0510","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00228-005-0088-5","article-title":"A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials","volume":"62","author":"Macedo","year":"2006","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0515","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2796.2005.01470.x","article-title":"Preferring patient-reported to observer-reported outcomes substantially influences the results of the updated systematic review on placebos by Hr\u00f3bjartsson and G\u00f8tzsche","volume":"257","author":"Meissner","year":"2005","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0520","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jamainternmed.2013.10391","article-title":"Differential effectiveness of placebo treatments: A systematic review of migraine prophylaxis","volume":"173","author":"Meissner","year":"2013","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0525","series-title":"International Review of Neurobiology","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/bs.irn.2018.07.014","article-title":"Are blue pills better than green? How treatment features modulate placebo effects","author":"Meissner","year":"2018"},{"key":"10.1016\/bs.irn.2020.04.003_bb0530","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/mds.20935","article-title":"Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation","volume":"21","author":"Mercado","year":"2006","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0535","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/mds.26500","article-title":"Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects: Factors influencing deep brain stimulation outcome","volume":"31","author":"Mestre","year":"2016","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0540","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/mds.27409","article-title":"Harnessing the power of placebos in movement disorders: Insights from Parkinson's disease in clinical research and practice: Harnessing the power of placebos","volume":"33","author":"Mestre","year":"2018","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0545","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/WCO.0000000000000313","article-title":"Nocebo in headache","volume":"29","author":"Mitsikostas","year":"2016","journal-title":"Current Opinion in Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0550","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0333102410391485","article-title":"Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches","volume":"31","author":"Mitsikostas","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/bs.irn.2020.04.003_bb0555","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/08039488.2018.1468480","article-title":"The Hawthorne effect as a pre-placebo expectation in Parkinsons disease patients participating in a randomized placebo-controlled clinical study","volume":"72","author":"Morberg","year":"2018","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2020.04.003_bb0560","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pain.2009.07.026","article-title":"Reproducibility of placebo analgesia: Effect of dispositional optimism","volume":"146","author":"Morton","year":"2009","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0565","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.parkreldis.2015.07.020","article-title":"Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program","volume":"21","author":"Odin","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0570","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1093\/brain\/awn116","article-title":"Placebo effects: Clinical aspects and neurobiology","volume":"131","author":"Oken","year":"2008","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0575","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/13803390701775428","article-title":"Expectancy effect: Impact of pill administration on cognitive performance in healthy seniors","volume":"30","author":"Oken","year":"2008","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0580","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5664\/jcsm.5396","article-title":"Post hoc analysis of data from two clinical trials evaluating the minimal clinically important change in international restless legs syndrome sum score in patients with restless legs syndrome (Willis-Ekbom disease)","volume":"12","author":"Ondo","year":"2016","journal-title":"Journal of Clinical Sleep Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0585","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/01.wnl.0000200779.03748.0f","article-title":"Topiramate in essential tremor: A double-blind, placebo-controlled trial","volume":"66","author":"Ondo","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0590","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/1352458510370793","article-title":"Nocebo effects in multiple sclerosis trials: A meta-analysis","volume":"16","author":"Papadopoulos","year":"2010","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/bs.irn.2020.04.003_bb0595","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00415-011-6197-4","article-title":"A meta-analytic approach to estimating nocebo effects in neuropathic pain trials","volume":"259","author":"Papadopoulos","year":"2012","journal-title":"Journal of Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0600","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/09658211.2011.592500","article-title":"A sham drug improves a demanding prospective memory task","volume":"19","author":"Parker","year":"2011","journal-title":"Memory"},{"key":"10.1016\/bs.irn.2020.04.003_bb0605","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/jnnp-2012-304181","article-title":"A systematic review of transcranial magnetic stimulation in the treatment of functional (conversion) neurological symptoms","volume":"85","author":"Pollak","year":"2014","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2020.04.003_bb0610","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3959(01)00296-2","article-title":"Response expectancies in placebo analgesia and their clinical relevance","volume":"93","author":"Pollo","year":"2001","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0615","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/00001756-200208070-00006","article-title":"Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients","volume":"13","author":"Pollo","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/bs.irn.2020.04.003_bb0620","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3389\/fpsyt.2019.00525","article-title":"Placebo effects on visual food Cue reactivity: An eye-tracking investigation","volume":"10","author":"Potthoff","year":"2019","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/bs.irn.2020.04.003_bb0625","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/mds.27438","article-title":"Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going: Placebo effect in PD","volume":"33","author":"Quattrone","year":"2018","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0630","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbr.2015.12.021","article-title":"Placebo effects induced by auditory cues decrease parkinsonian rigidity in patients with subthalamic stimulation","volume":"301","author":"R\u00e4tsep","year":"2016","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.irn.2020.04.003_bb0635","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s13063-017-2174-2","article-title":"Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials","volume":"18","author":"Reijula","year":"2017","journal-title":"Trials"},{"key":"10.1016\/bs.irn.2020.04.003_bb0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050166","article-title":"Greater response to placebo in children than in adults: A systematic review and meta-analysis in drug-resistant partial epilepsy","volume":"5","author":"Rheims","year":"2008","journal-title":"PLoS Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0645","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1684\/epd.2012.0533","article-title":"Patient and physician preferences: Impact on treatment effectiveness","volume":"14","author":"Rheims","year":"2012","journal-title":"Epileptic Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0650","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s10865-011-9374-0","article-title":"Choice and placebo expectation effects in the context of pain analgesia","volume":"35","author":"Rose","year":"2012","journal-title":"Journal of Behavioral Medicine"},{"key":"10.1016\/bs.irn.2020.04.003_bb0655","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1124\/pr.114.009423","article-title":"Neuro-bio-behavioral mechanisms of placebo and nocebo responses: Implications for clinical trials and clinical practice","volume":"67","author":"Schedlowski","year":"2015","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.irn.2020.04.003_bb0660","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ncl.2016.01.001","article-title":"Patient education: Identifying risks and self-management approaches for adherence and sudden unexpected death in epilepsy","volume":"34","author":"Shafer","year":"2016","journal-title":"Neurologic Clinics"},{"key":"10.1016\/bs.irn.2020.04.003_bb0665","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/21678421.2017.1335325","article-title":"Nocebo in motor neuron disease: Systematic review and meta-analysis of placebo-controlled clinical trials","volume":"18","author":"Shafiq","year":"2017","journal-title":"Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration"},{"key":"10.1016\/bs.irn.2020.04.003_bb0670","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.parkreldis.2016.05.019","article-title":"Predictors of the placebo response in clinical trials on Parkinson's disease: A meta-analysis","volume":"29","author":"Shin","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0675","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1212\/WNL.0000000000004004","article-title":"Placebo and nocebo responses in restless legs syndrome: A systematic review and meta-analysis","volume":"88","author":"Silva","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0680","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fphar.2019.00809","article-title":"Nocebo in biosimilars and generics in neurology: A systematic review","volume":"10","author":"Spanou","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0685","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/ene.12014","article-title":"Nocebo as a potential confounding factor in clinical trials for Parkinson's disease treatment: A meta-analysis","volume":"20","author":"Stathis","year":"2013","journal-title":"European Journal of Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0690","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.pain.2012.07.010","article-title":"White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia","volume":"153","author":"Stein","year":"2012","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0695","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1212\/WNL.0b013e31825fdf63","article-title":"Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs","volume":"79","author":"Stone","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0700","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/mdc3.12785","article-title":"How do I explain the diagnosis of functional movement disorder to a patient?","volume":"6","author":"Stone","year":"2019","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.1016\/bs.irn.2020.04.003_bb0705","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.neuroimage.2006.02.005","article-title":"Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: The contribution of expectation","volume":"31","author":"Strafella","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/bs.irn.2020.04.003_bb0710","doi-asserted-by":"crossref","first-page":"a1938","DOI":"10.1136\/bmj.a1938","article-title":"Prescribing \u201cplacebo treatments\u201d: Results of national survey of US internists and rheumatologists","volume":"337","author":"Tilburt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/bs.irn.2020.04.003_bb0715","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/mds.26659","article-title":"A phase 2A trial of the novel mGluR5-negative allosteric modulator dipraglurant for levodopa-induced dyskinesia in Parkinson's disease: Dipraglurant in levodopa-induced dyskinesia","volume":"31","author":"Tison","year":"2016","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0720","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13760-019-01143-1","article-title":"Nocebo effect in myasthenia gravis: Systematic review and meta-analysis of placebo-controlled clinical trials","volume":"119","author":"Varma","year":"2019","journal-title":"Acta Neurologica Belgica"},{"key":"10.1016\/bs.irn.2020.04.003_bb0725","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrn3976","article-title":"The neuroscience of placebo effects: Connecting context, learning and health","volume":"16","author":"Wager","year":"2015","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.irn.2020.04.003_bb0730","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1523\/JNEUROSCI.3420-10.2011","article-title":"Predicting individual differences in placebo analgesia: Contributions of brain activity during anticipation and pain experience","volume":"31","author":"Wager","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2020.04.003_bb0735","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1037\/hea0000416","article-title":"A systematic review of factors that contribute to nocebo effects","volume":"35","author":"Webster","year":"2016","journal-title":"Health Psychology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0740","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17470218.2012.751117","article-title":"Mobilizing unused resources: Using the placebo concept to enhance cognitive performance","volume":"66","author":"Weger","year":"2013","journal-title":"The Quarterly Journal of Experimental Psychology (Hove)"},{"key":"10.1016\/bs.irn.2020.04.003_bb0745","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-3-662-44519-8_14","article-title":"Traditional and innovative experimental and clinical trial designs and their advantages and pitfalls","volume":"225","author":"Weimer","year":"2014","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/bs.irn.2020.04.003_bb0750","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7224\/1537-2073.2014-105","article-title":"Development and feasibility of an evidence-based patient education program for managing fatigue in multiple sclerosis: The \u201cfatigue management in MS\u201d program (FatiMa)","volume":"18","author":"Wendebourg","year":"2016","journal-title":"International Journal of MS Care"},{"key":"10.1016\/bs.irn.2020.04.003_bb0755","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/mds.27416","article-title":"What influences placebo and nocebo responses in Parkinson's disease?: Placebo and nocebo response in PD","volume":"33","author":"Witek","year":"2018","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0760","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jpain.2016.08.012","article-title":"Preserved capacity for placebo analgesia in the elderly","volume":"17","author":"Wrobel","year":"2016","journal-title":"The Journal of Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0765","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jpain.2015.06.013","article-title":"Are children the better placebo analgesia responders? An experimental approach","volume":"16","author":"Wrobel","year":"2015","journal-title":"The Journal of Pain"},{"key":"10.1016\/bs.irn.2020.04.003_bb0770","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cortex.2014.02.023","article-title":"Haloperidol blocks dorsal striatum activity but not analgesia in a placebo paradigm","volume":"57","author":"Wrobel","year":"2014","journal-title":"Cortex"},{"key":"10.1016\/bs.irn.2020.04.003_bb0775","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.msard.2015.06.010","article-title":"Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction","volume":"4","author":"Zimmer","year":"2015","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"10.1016\/bs.irn.2020.04.003_bb0780","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2018.03.009","article-title":"Nocebo in chronic inflammatory demyelinating polyneuropathy; a systematic review and meta-analysis of placebo-controlled clinical trials","volume":"388","author":"Zis","year":"2018","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/bs.irn.2020.04.003_bb0785","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jns.2015.05.029","article-title":"Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials","volume":"355","author":"Zis","year":"2015","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/bs.irn.2020.04.003_bb0790","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.seizure.2016.12.003","article-title":"Nocebo effect in refractory partial epilepsy during pre-surgical monitoring: Systematic review and meta-analysis of placebo-controlled clinical trials","volume":"45","author":"Zis","year":"2017","journal-title":"Seizure"}],"container-title":["International Review of Neurobiology","Placebo Effects in Neurologic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774220300672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774220300672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:12:29Z","timestamp":1758748349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774220300672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128211182"],"references-count":157,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2020.04.003","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}